About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalChina
Clinical Trials (73)
View allTotal Trials
73
As Lead Sponsor
73
As Collaborator
0
Total Enrollment
11,995
By Phase
PHASE1: 23PHASE3: 17PHASE4: 7PHASE2: 8PHASE1/PHASE2: 7NA: 5PHASE2/PHASE3: 4
By Status
UNKNOWN: 36COMPLETED: 29RECRUITING: 6SUSPENDED: 1WITHDRAWN: 1
Clinical Trials Pipeline73 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06953453Lead Sponsor
A Study of Inhaled Fentanyl Aerosol in Chinese Patients With Malignant Tumors
PHASE1Recruiting
100 participants
Started: Sep 23, 2025 · Completed: Aug 20, 2026
NCT06160492Lead Sponsor
Phase III Clinical Trial Evaluating the Resection Efficacy of 5-Aminolevulinic Acid Hydrochloride (5-ALA HCl) Fluorescence-Guided Microsurgery Versus Conventional White Light Microsurgery in Patients With Malignant Glioma (WHO Grade 3/4)
PHASE3Recruiting
144 participants
Started: Apr 14, 2025 · Completed: Mar 31, 2026
NCT07099144Lead Sponsor
Inhaled Nitric Oxide for the Treatment of Neonatal Hypoxic Respiratory Failure With Pulmonary Hypertension
N/ARecruiting
120 participants
Started: Dec 12, 2024 · Completed: Dec 30, 2026
NCT06459687Lead Sponsor
Phase III Study of Socazolimab as First-Line Treatment in Persistent, Recurrent, or Metastatic Cervical Cancer
PHASE3Recruiting
440 participants
Started: Nov 28, 2024 · Completed: Sep 1, 2028
NCT06374485Lead Sponsor
Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment
PHASE1Recruiting
18 participants
Started: May 21, 2024 · Completed: Dec 31, 2025
Locations (1)
Headquarters
Guangzhou, China
Map
Loading map...